COPERNIC: A study of on-treatment circulating tumour (ct) DNA changes in chemo-refractory colorectal cancer (CRC) patients

被引：0

作者：

Assaf, I. ^{[1
]}

Bregni, G. ^{[1
]}

Anthoine, G. ^{[2
]}

Aparicio, T. ^{[3
]}

Artru, P. ^{[4
]}

Ben Abdelghani, M. ^{[5
]}

Chibaudel, B. ^{[6
]}

Coart, E. ^{[7
]}

Diaz, M. ^{[8
]}

Evrard, C. ^{[9
]}

Geboes, K. ^{[10
]}

Ghiringhelli, F. ^{[11
]}

Puleo, F. ^{[12
]}

Raimbourg, J. ^{[13
]}

Vandamme, T. ^{[14
]}

van den Eynde, M. ^{[15
]}

Hendlisz, A. ^{[1
]}

Sclafani, F. ^{[1
]}

机构：

[1] Univ Libre Bruxelles ULB, Hop Univ Bruxelles HUB, Inst Jules Bordet, Dept Gastrointestinal Oncol, Anderlecht, Belgium

[2] Univ Libre Bruxelles ULB, Hop Univ Bruxelles HUB, Inst Jules Bordet, GI Lab, Anderlecht, Belgium

[3] Hop St Louis, AP HP, Dept Gastroenterol & Digest Oncol, Paris, France

[4] Hop Prive Jean Mermoz, Dept Gastrointestinal Oncol, Lyon, France

[5] ICANS Inst Cancerol Strasbourg Europe, Dept Oncol, Strasbourg, France

[6] Fdn Cognacq Jay, HFB Hop Franco Britann, Dept Med Oncol, Levallois Perret, France

[7] Int Inst Drug Dev, Biostat, Louvain, Belgium

[8] Hosp Ambroise Pare, Dept Oncol, Mons, Belgium

[9] CHU Poitiers Jean Bernard Hop, Dept Oncol, Poitiers, France

[10] UZ Gent, Dept Gastroenterol, Univ Hosp Ghent, Ghent, Belgium

[11] Ctr Georges Francois Leclerc Dijon, Dept Med Oncol, Dijon, France

[12] Chirec Delta, Dept Med Oncol, Auderghem, Belgium

[13] ICO Inst Cancerol Ouest Rene Gauducheau, Dept Med Oncol, St Herblain, France

[14] UZA Univ Hosp Antwerp, Dept Oncol, Edegem, Belgium

[15] UCLouvain St Luc, Dept Digest Oncol, Clin Univ St Luc, Woluwe St Lambert, Belgium

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.05.169

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

159TiP

引用

页码：S70 / S71

页数：2

共 50 条

[21] Profiling circulating tumor (ct)DNA mutations after panitumumab treatment in patients with refractory metastatic colorectal cancer (mCRC) from the phase III ASPECCT study.
Boedigheimer, Michael
Ang, Agnes
Price, Timothy Jay
Peeters, Marc
Kim, Tae Won
Gibbs, Peter
Thomas, Anne L.
Hool, Kristina
Bach, Bruce A.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[22] CIRCULATING TUMOUR DNA (ctDNA) IN PATIENTS WITH METASTATIC COLORECTAL CANCER (mCRC): PROGNOSTIC SIGNIFICANCE AND EARLY CHANGES DURING CHEMOTHERAPY
Tie, J.
Kinde, I.
Wong, H. -L.
McKendrick, J.
Singh, M.
Karapetis, C.
Desai, J.
Tran, B.
Roebert, J.
Kinzler, K.
Vogelstein, B.
Gibbs, P.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 50 - 50
[23] Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
Ogaard, Nadia
Jensen, Sarah Ostrup
Orntoft, Mai-Britt Worm
Demuth, Christina
Rasmussen, Mads Heilskov
Henriksen, Tenna Vesterman
Nors, Jesper
Frydendahl, Amanda
Lyskjaer, Iben
Nesic, Marijana
Therkildsen, Christina
Kleif, Jakob
Gogenur, Mikail
Jorgensen, Lars Nannestad
Vilandt, Jesper
Seidelin, Jakob Benedict
Gotschalck, Kare Anderson
Jaensch, Claudia
Andersen, Berit
Love, Uffe Schou
Thorlacius-Ussing, Ole
Andersen, Per Vadgaard
Kolbro, Thomas
Monti, Alessio
Kildsig, Jeppe
Bondeven, Peter
Schlesinger, Nis Hallundbaek
Iversen, Lene Hjerrild
Rasmussen, Morten
Gogenur, Ismail
Bramsen, Jesper Bertram
Andersen, Claus Lindbjerg
BRITISH JOURNAL OF CANCER, 2024, : 1707 - 1715
[24] The Prognostic Utility of KRAS Mutations in Tissue and Circulating Tumour DNA in Colorectal Cancer Patients
Petit, Joel
Carroll, Georgia
Zhao, Jie
Pockney, Peter
Scott, Rodney J.
GASTROENTEROLOGY INSIGHTS, 2024, 15 (01) : 107 - 121
[25] NSABP FC-10: Phase IB study of pembrolizumab in combination with premetrexed plus oaliplatin in patients (pts) with chemo-refractory metastatic colorectal cancer (mCRC)
Lee, James J.
Yothers, Greg
George, Thomas J.
Krauss, John C.
Maalouf, Bassam Nabih
Parekh, Hiral D.
Krishnamurthy, Anuradha
Vehec, Kelly R.
Wolmark, Norman
Allegra, Carmen Joseph
Jacobs, Samuel A.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[26] Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study
Chen, Kezhong
Zhao, Heng
Yang, Fan
Hui, Bengang
Wang, Tianyang
Wang, Lieu Tu
Shi, Yanbin
Wang, Jun
BMJ OPEN, 2018, 8 (02):
[27] Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
Ng, Sarah B.
Chua, Clarinda
Ng, Matthew
Gan, Anna
Poon, Polly Sy
Teo, Melissa
Fu, Cherylin
Leow, Wei Qiang
Lim, Kiat Hon
Chung, Alexander
Koo, Si-Lin
Choo, Su Pin
Ho, Danliang
Rozen, Steve
Tan, Patrick
Wong, Mark
Burkholder, William F.
Tan, Iain Beehuat
SCIENTIFIC REPORTS, 2017, 7
[28] Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA
Ye, Liu-Fang
Huang, Zi-Yao
Chen, Xiao-Xi
Chen, Zhi-Gang
Wu, Si-Xian
Ren, Chao
Hu, Ming-Tao
Bao, Hua
Jin, Ying
Wang, Feng
Wang, Feng-Hua
Du, Zi-Ming
Wu, Xue
Ju, Huai-Qiang
Shao, Yang
Li, Yu-Hong
Xu, Rui-Hua
Wang, De-Shen
DRUG RESISTANCE UPDATES, 2022, 65
[29] Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
Sarah B. Ng
Clarinda Chua
Matthew Ng
Anna Gan
Polly SY Poon
Melissa Teo
Cherylin Fu
Wei Qiang Leow
Kiat Hon Lim
Alexander Chung
Si-Lin Koo
Su Pin Choo
Danliang Ho
Steve Rozen
Patrick Tan
Mark Wong
William F. Burkholder
Iain Beehuat Tan
Scientific Reports, 7
[30] Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients
Loupakis, F.
Antoniotti, C.
Cremolini, C.
Zhang, W.
Yang, D.
Wakatsuki, T.
Bohanes, P.
Schirripa, M.
Salvatore, L.
Masi, G.
Ricci, V.
Graziano, F.
Ruzzo, A.
Benhaim, L.
Marmorino, F.
Ning, Y.
El-Khoueiry, R.
Falcone, A.
Lenz, H-J
PHARMACOGENOMICS JOURNAL, 2014, 14 (04): : 322 - 327

← 1 2 3 4 5 →